These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33843539)

  • 21. [Epidemiology of infection in Germany].
    Fock RR; Kordel-Bödigheimer M; Schwartländer B
    Z Arztl Fortbild (Jena); 1995 Jun; 89(3):203-10. PubMed ID: 7668006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the use of web searches for risk communication during COVID-19 in Germany.
    Kristensen K; Lorenz E; May J; Strauss R
    Sci Rep; 2021 Mar; 11(1):6419. PubMed ID: 33742054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of real-time surveillance of influenza incidence in Kawasaki City by comparison using the National Epidemiological Surveillance of Infectious Diseases].
    Nakamura T; Maruyama A; Misaki T; Okabe N; Shinmei K; Hashizume M; Murakami Y; Nishiwaki Y
    Nihon Koshu Eisei Zasshi; 2018; 65(11):666-676. PubMed ID: 30518705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Field investigations of SARS-CoV-2-outbreaks in Germany by the Robert Koch Institute, February-October 2020].
    Alpers K; Haller S; Buchholz U;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Apr; 64(4):446-453. PubMed ID: 33733292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk communication of the Federal Institute for Risk Assessment during a food-related outbreak].
    Lohmann M; Epp A; Röder B; Böl GF
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Jan; 56(1):102-9. PubMed ID: 23275962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-thinking risk communication: information needs of patients, health professionals and the public regarding MRSA--the communicative behaviour of a public health network in Germany responding to the demand for information.
    Dickmann P; Wittgens K; Keeping S; Mischler D; Heudorf U
    Public Health; 2016 Feb; 131():56-62. PubMed ID: 26710665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Integrated bulletin for the automated surveillance of notifiable communicable diseases in Schleswig-Holstein (IBISSH). A spatiotemporal early warning system].
    Läubrich C; Bocter N; Fickenscher H; Selck G; Rautenberg P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):875-84. PubMed ID: 21698542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Integration of secondary data into national diabetes surveillance : Background, aims and results of the secondary data workshop at the Robert Koch Institute].
    Schmidt C; Bätzing-Feigenbaum J; Bestmann A; Brinks R; Dreß J; Goffrier B; Hagen B; Laux G; Pollmanns J; Schröder H; Stahl T; Baumert J; Du Y; Gabrys L; Heidemann C; Paprott R; Scheidt-Nave C; Teti A; Ziese T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Jun; 60(6):656-661. PubMed ID: 28466131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infectious disease surveillance based on the Protection against Infection Act in the German public health sector].
    Dreesman J; Benzler J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):979-89. PubMed ID: 16160885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influenza and community acquired pneumonia in German primary care].
    Zanuzdana A; Köpke K; Haas W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Nov; 59(11):1492-1502. PubMed ID: 27695937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing an ICD-10 code based SARI-surveillance in Germany - description of the system and first results from five recent influenza seasons.
    Buda S; Tolksdorf K; Schuler E; Kuhlen R; Haas W
    BMC Public Health; 2017 Jun; 17(1):612. PubMed ID: 28666433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The RISKSUR EVA tool (Survtool): A tool for the integrated evaluation of animal health surveillance systems.
    Peyre M; Hoinville L; Njoroge J; Cameron A; Traon D; Goutard F; Calba C; Grosbois V; Delabouglise A; Varant V; Drewe J; Pfeiffer D; Häsler B
    Prev Vet Med; 2019 Dec; 173():104777. PubMed ID: 31731037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical usage of computer-supported outbreak detection in five European countries.
    Hulth A; Andrews N; Ethelberg S; Dreesman J; Faensen D; van Pelt W; Schnitzler J
    Euro Surveill; 2010 Sep; 15(36):. PubMed ID: 20843470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FIFA World Cup 2006 in Germany: enhanced surveillance improved timeliness and detection.
    Williams CJ; Schenkel K; Eckmanns T; Altmann D; Krause G
    Epidemiol Infect; 2009 Apr; 137(4):597-605. PubMed ID: 18667109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of German National Reference Centres on monitoring of antibiotic resistance.
    Kist M
    Int J Med Microbiol; 2006 Jun; 296 Suppl 41():55-61. PubMed ID: 17024755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes Surveillance in Germany - Background, concept and prospects.
    Gabrys L; Schmidt C; Heidemann C; Baumert J; Du Y; Paprott R; Teti A; Wolf IK; Ziese T; Scheidt-Nave C
    J Health Monit; 2017 Mar; 2(1):83-95. PubMed ID: 37168685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Communicating with participants during the conduct of multi-center clinical trials.
    Augustine EF; Dorsey ER; Hauser RA; Elm JJ; Tilley BC; Kieburtz KK
    Clin Trials; 2016 Dec; 13(6):592-596. PubMed ID: 27573636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adaptation of the routine surveillance system for infectious diseases in 2020 in the context of the COVID-19 pandemic].
    Diercke M; Claus H; Rexroth U; Hamouda O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Apr; 64(4):388-394. PubMed ID: 33847762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meeting the International Health Regulations (2005) surveillance core capacity requirements at the subnational level in Europe: the added value of syndromic surveillance.
    Ziemann A; Rosenkötter N; Riesgo LG; Fischer M; Krämer A; Lippert FK; Vergeiner G; Brand H; Krafft T
    BMC Public Health; 2015 Feb; 15():107. PubMed ID: 25879869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.